Topical treatment of atopic dermatitis with Hypericum cream. A randomised, placebo-controlled, double-blind half-side comparison study;Behandlung der subakuten atopischen dermatitis mit Johanniskraut-creme: Eine randomisierte, placebokontrollierte doppelblindstudie im halbseitendesign

Hautarzt

Volumn 54, Issue 3, 2003, Pages 248-253

  Schempp, C M ^a   Hezel, S ^a   Simon, J C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Half side comparison; Hyperforin; Phytotherapy; Randomized clinical trial; Severity Scoring of Atopic Dermatitis

Indexed keywords

HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; PLACEBO;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ECZEMA; HUMAN; OUTCOMES RESEARCH; PARAMETER; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS;

EID: 0037525270     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Aertgeerts P, Albring M, Klaschka F, Nasemann T, Patzelt-Wenczler, Rauhhut K, Weigl B (1985) Vergleichende Prüfung von Kamillosan-Creme gegenüber steroidalen (0,25% Hydrocortison, 0,75% Fluocortinbutylester) und nichtsteroidalen (5% Bufexamac) Externa in der Erhaltungstherapie von Ekzemerkrankungen. Z Hautkr 60:270-277
2. European Task force on Atopic Dermatitis (1993) Severity Scoring of Atopic Dermatitis: the SCORAD Index. Consensus Report of the European Task force on Atopic Dermatitis. Dermatology 186:23-31
3. Gniazdowska B, Rueff F, Przybilla B (1999) Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs. Contact Dermatitis 40:63-65.
4. Gurevich AI, Dobrynin VN, Kolosov MN et al. (1971) Hyperforin, an antibiotic from Hypericum perforatum L. Antibiotiki 16:510-513
5. Korting HC, Schafer-Korting M, Klovekorn W, Klovekorn G, Martin C, Laux P (1995) Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema. Eur J Clin Pharm 48:461-465
6. Maisenbacher P, Kovar KA (1992) Analysis and stability of Hyperici oleum. Planta Med 58:351-354
7. Mezger J (1991) Gesichtete homöopathische Arzneimittellehre: Hypericum perforatum. Haug, Heidelberg, S761-765
8. Niedner R (1996) Solanum dulcamara L. - a "plant cortisone"? Med Mon Pharm 19:339-340
9. Patzelt-Wenczler R, Ponce-Poschl E (2000) Proof of efficacy of Kamillosan(R) cream in atopic eczema. Eur J Med Res 19:171-175
10. Roth L (1990) Hypericum - Hypericin. Botanik, Inhaltsstoffe, Wirkungen. Ecomed Arzneipflanzen-Monographie. Ecomed, Landsberg/Lech
11. Schempp CM, Pelz K, Wittmer A, Schöpf E, Simon JC (1999) Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria. Lancet 353:2129
12. Schempp CM, Winghofer B, Lüdtke R, Simon-Haarhaus, Schöpf E, Simon JC (2000/1) Effect of topical application of Hypericum perforatum extract (St. John's wort) on skin sensitivity to solar simulated radiation. Photodermatol Photoimmunol Photomed 16:125-128
13. Schempp CM, Winghofer B, Lüdtke R, Simon-Haarhaus, Schöpf E, Simon JC (2000/2) Topical application of St. John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Br J Dermatol 142:979-984
14. Schempp CM, Müller KA, Winghofer B, Schöpf E, Simon JC (2002/1) Johanniskraut (Hypericum perforatum L.)-eine Pflanze mit Relevanz für die Dermatologie. Hautarzt 53:316-321
15. Schempp CM, Schöpf E, Simon JC (2002/2) Durch Pflanzen ausgelöste toxische und allergische Dermatitis (Phytodermatitis). Hautarzt S3:93-97
16. Sears HW, Bailer JW, Yeadon A (1997) Efficacy and safety of hydrocortisone Buteprate 0,1% cream in patients with atopic dermatitis. Clin Ther 19:710-719
17. Swoboda M, Meurer J (1991) Therapie von Neurodermitis durch Hamamelis virginiana-Extrakt in Salbenform. Z Phytother 12:114-117
18. Thumm EJ, Stoss M, Bayed C, Schürholz T (2000) Überprüfung der Wirksamkeit einer 20%igen und 10%igen Sanddornkernölcreme bei Patienten mit leichter bis mittelgradiger atopischer Dermatitis. Akt Dermatol 26:285-290